List of Kobayashi Pharmaceutical Co., Ltd. patents

Patent 10980665 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on April, 2021 by the United States Patent and Trademark Office.

Patent 10993833 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on May, 2021 by the United States Patent and Trademark Office.

Patent 11241331 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on February, 2022 by the United States Patent and Trademark Office.

Patent D959685 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on August, 2022 by the United States Patent and Trademark Office.

Patent D985132 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on May, 2023 by the United States Patent and Trademark Office.

Patent D979778 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on February, 2023 by the United States Patent and Trademark Office.

Patent D985783 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on May, 2023 by the United States Patent and Trademark Office.

Patent 11026771 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on June, 2021 by the United States Patent and Trademark Office.

Patent D985133 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on May, 2023 by the United States Patent and Trademark Office.

Patent 11358312 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Patent 11351705 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Patent 11633269 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on April, 2023 by the United States Patent and Trademark Office.

Patent D951466 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on May, 2022 by the United States Patent and Trademark Office.

Patent D951467 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on May, 2022 by the United States Patent and Trademark Office.

Patent 11534377 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on December, 2022 by the United States Patent and Trademark Office.

Patent D946160 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on March, 2022 by the United States Patent and Trademark Office.

Patent D946161 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on March, 2022 by the United States Patent and Trademark Office.

Patent D961790 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on August, 2022 by the United States Patent and Trademark Office.

Patent 11427733 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on August, 2022 by the United States Patent and Trademark Office.

Patent 11406804 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on August, 2022 by the United States Patent and Trademark Office.

Patent D946162 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on March, 2022 by the United States Patent and Trademark Office.

Patent 11478341 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on October, 2022 by the United States Patent and Trademark Office.

Patent D912260 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on March, 2021 by the United States Patent and Trademark Office.

Patent D627078 was granted and assigned to Kobayashi Pharmaceutical Co., Ltd. on November, 2010 by the United States Patent and Trademark Office.